938 related articles for article (PubMed ID: 32155866)
1. The Diabetes Mellitus-Atherosclerosis Connection: The Role of Lipid and Glucose Metabolism and Chronic Inflammation.
Poznyak A; Grechko AV; Poggio P; Myasoedova VA; Alfieri V; Orekhov AN
Int J Mol Sci; 2020 Mar; 21(5):. PubMed ID: 32155866
[TBL] [Abstract][Full Text] [Related]
2. Do glucose and lipids exert independent effects on atherosclerotic lesion initiation or progression to advanced plaques?
Kanter JE; Johansson F; LeBoeuf RC; Bornfeldt KE
Circ Res; 2007 Mar; 100(6):769-81. PubMed ID: 17395883
[TBL] [Abstract][Full Text] [Related]
3. The role of insulin resistance in the pathogenesis of atherosclerotic cardiovascular disease: an updated review.
Reddy KJ; Singh M; Bangit JR; Batsell RR
J Cardiovasc Med (Hagerstown); 2010 Sep; 11(9):633-47. PubMed ID: 20164784
[TBL] [Abstract][Full Text] [Related]
4. Review article: diabetes and atherosclerosis--running on a common road.
Federici M; Lauro R
Aliment Pharmacol Ther; 2005 Nov; 22 Suppl 2():11-5. PubMed ID: 16225464
[TBL] [Abstract][Full Text] [Related]
5. The dysregulated adipose tissue: a connecting link between insulin resistance, type 2 diabetes mellitus and atherosclerosis.
Murdolo G; Smith U
Nutr Metab Cardiovasc Dis; 2006 Mar; 16 Suppl 1():S35-8. PubMed ID: 16530128
[TBL] [Abstract][Full Text] [Related]
6. Diabetes Mellitus to Accelerated Atherosclerosis: Shared Cellular and Molecular Mechanisms in Glucose and Lipid Metabolism.
Zhao N; Yu X; Zhu X; Song Y; Gao F; Yu B; Qu A
J Cardiovasc Transl Res; 2024 Feb; 17(1):133-152. PubMed ID: 38091232
[TBL] [Abstract][Full Text] [Related]
7. New insights into oxidative stress and inflammation during diabetes mellitus-accelerated atherosclerosis.
Yuan T; Yang T; Chen H; Fu D; Hu Y; Wang J; Yuan Q; Yu H; Xu W; Xie X
Redox Biol; 2019 Jan; 20():247-260. PubMed ID: 30384259
[TBL] [Abstract][Full Text] [Related]
8. Molecular and signaling mechanisms of atherosclerosis in insulin resistance.
Schwartz EA; Reaven PD
Endocrinol Metab Clin North Am; 2006 Sep; 35(3):525-49, viii. PubMed ID: 16959584
[TBL] [Abstract][Full Text] [Related]
9. Beneficial Effects of Adiponectin on Glucose and Lipid Metabolism and Atherosclerotic Progression: Mechanisms and Perspectives.
Yanai H; Yoshida H
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30857216
[TBL] [Abstract][Full Text] [Related]
10. The relationship of abnormal circulating insulin levels to atherosclerosis.
Stout RW
Atherosclerosis; 1977 May; 27(1):1-13. PubMed ID: 857812
[TBL] [Abstract][Full Text] [Related]
11. Aerobic exercise regulates blood lipid and insulin resistance via the toll‑like receptor 4‑mediated extracellular signal‑regulated kinases/AMP‑activated protein kinases signaling pathway.
Wang M; Li S; Wang F; Zou J; Zhang Y
Mol Med Rep; 2018 Jun; 17(6):8339-8348. PubMed ID: 29658605
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D, sub-inflammation and insulin resistance. A window on a potential role for the interaction between bone and glucose metabolism.
Garbossa SG; Folli F
Rev Endocr Metab Disord; 2017 Jun; 18(2):243-258. PubMed ID: 28409320
[TBL] [Abstract][Full Text] [Related]
13. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
14. The potential biological mechanisms of arsenic-induced diabetes mellitus.
Tseng CH
Toxicol Appl Pharmacol; 2004 Jun; 197(2):67-83. PubMed ID: 15163543
[TBL] [Abstract][Full Text] [Related]
15. Metabolic syndrome, inflammation and atherosclerosis.
Paoletti R; Bolego C; Poli A; Cignarella A
Vasc Health Risk Manag; 2006; 2(2):145-52. PubMed ID: 17319458
[TBL] [Abstract][Full Text] [Related]
16. Role of reactive oxygen species in the progression of type 2 diabetes and atherosclerosis.
Kaneto H; Katakami N; Matsuhisa M; Matsuoka TA
Mediators Inflamm; 2010; 2010():453892. PubMed ID: 20182627
[TBL] [Abstract][Full Text] [Related]
17. Association between insulin resistance and the development of cardiovascular disease.
Ormazabal V; Nair S; Elfeky O; Aguayo C; Salomon C; Zuñiga FA
Cardiovasc Diabetol; 2018 Aug; 17(1):122. PubMed ID: 30170598
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of postprandial hyperglycemia by acarbose is a promising therapeutic strategy for the treatment of patients with the metabolic syndrome.
Yamagishi S; Nakamura K; Takeuchi M
Med Hypotheses; 2005; 65(1):152-4. PubMed ID: 15893133
[TBL] [Abstract][Full Text] [Related]
19. A rational approach to pathogenesis and treatment of type 2 diabetes mellitus, insulin resistance, inflammation, and atherosclerosis.
Dandona P; Aljada A
Am J Cardiol; 2002 Sep; 90(5A):27G-33G. PubMed ID: 12231076
[TBL] [Abstract][Full Text] [Related]
20. Oxidative stress in insulin-resistant conditions: cardiovascular implications.
Stump CS; Clark SE; Sowers JR
Treat Endocrinol; 2005; 4(6):343-51. PubMed ID: 16318400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
